Points of interest…
- Anne Bethune opened Missouri's first ketamine practice in 2019, logging 500+ sessions.
- Ketamine, a Schedule III drug, treats depression, PTSD, and suicidal thoughts off-label.
- NASW has no ketamine-specific code, so social workers apply general ethics rules.
A ketamine infusion can alter neurochemistry in under an hour. What changes the person is the clinical relationship around the dose. That split frames the emerging role of licensed clinical social workers in ketamine-assisted therapy, a growing career opportunity in social work.
In Missouri, LCSW Anne Bethune opened KAP Kansas City in 2019 and has conducted more than 500 sessions, a direct challenge to the assumption that psychiatrists alone lead this work. State boards have not adopted a uniform ketamine scope rule, so competence claims outrun regulation.
What Is Ketamine Therapy and How Is It Used in Mental Health?
Ketamine is a dissociative anesthetic that, in lower doses, is used off-label to treat depression, PTSD, and acute suicidal thoughts.1 It is a Schedule III controlled substance.1 The medication itself is FDA-approved for anesthesia, not for psychiatric conditions.2 When clinics offer ketamine for mental health, they are using it off-label, most often as intravenous racemic ketamine.
Two medications, two regulatory paths
Ketamine and esketamine are related but not interchangeable. Racemic ketamine is a mixture of two mirror-image molecules and is typically given by IV in specialized clinics, though intramuscular, intranasal, and oral forms exist. Esketamine, sold as Spravato, is a single isolated form approved by the FDA as a nasal spray for treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior.3 In 2025, FDA approval expanded to allow esketamine as monotherapy for adults with MDD who have not responded adequately to at least two oral antidepressants.4 Esketamine is also Schedule III and is given under a restricted safety program with at least two hours of post-dose monitoring and driving restrictions.56
Why the speed matters
Unlike SSRIs, which often take weeks to build effect, ketamine and esketamine can reduce symptoms within hours to days. That rapid action makes them useful in crisis-oriented care, but it does not make them first-line depression treatments. For mental health social workers, the key point is that ketamine therapy is a regulated, medically supervised intervention, not a standalone psychotherapy method, and it requires interdisciplinary skills for social workers.
What Can Social Workers Actually Do in Ketamine-Assisted Therapy?
Ketamine-assisted therapy is still defining its professional boundaries, and licensed clinical social workers are increasingly recognized as central members of the care team. Within their existing clinical license, social workers can complete psychosocial assessments, screen for trauma and dissociation, prepare clients for the dosing session, provide psychotherapy during the altered-state experience, and lead integration and follow-up monitoring after the medicine wears off. These are not extensions of the license; they are core psychotherapy tasks applied to a new treatment context.
Where the Non-Medical Line Sits
Social workers do not prescribe ketamine, insert intravenous lines, adjust dosages, or manage vital signs as a medical intervention. Those acts remain with physicians, nurse practitioners, and other licensed prescribers. In most settings the social worker's role is to hold the therapeutic frame while the medical team manages the pharmacology. This division protects both the patient and the practitioner's license.
The Relational Transpersonal Model
A distinctive social work contribution is the relational transpersonal model, which treats the client's subjective experience as the primary material of therapy rather than a side effect of a drug protocol. The idea is that the therapeutic relationship, not the infusion itself, carries the healing. This framing fits social work theories and the person-in-environment perspective, keeping the intervention grounded in relationship, not procedure.
License, Setting, and State Law
How much a social worker can do depends on the license level (MSW vs LCSW), the clinic's delegation structure, and state scope-of-practice rules. Some settings use social workers only for intake and integration; others let clinical social workers co-facilitate the dosing session. The next section maps those differences by state.
State-By-State Scope of Practice for Social Workers in Ketamine Therapy
State social work boards have not adopted a uniform rule for ketamine-assisted therapy, so scope depends on specific board advisories and practice acts. The matrix below includes Missouri as a reference state and eight jurisdictions with distinct guidance, including one Canadian province where social work regulators have issued explicit psychedelic-assisted therapy rules. Missing cells indicate areas where current board guidance does not directly address the role of a given license level.
| State | LMSW/LSW Role | LCSW Role | Prescriber/Onsite Rule | Key Restriction |
|---|---|---|---|---|
| Missouri | No explicit board guidance identified as of August 2026. | Licensed clinical social workers can lead ketamine-assisted therapy practices and conduct sessions; KAP Kansas City has been LCSW-led since 2019. | A prescribing physician is required to provide ketamine, but onsite presence during psychotherapy is not specified in available guidance. | Social workers do not prescribe; ketamine must be obtained through a licensed physician, and Missouri has not published a dedicated social work scope advisory for ketamine-assisted therapy. |
| Alabama | May provide psychotherapy related to ketamine only as an adjunct provider inside a physician-led medical practice where a physician carries primary medical liability. | May be present during active ketamine administration only as an adjunct provider within a physician-led medical procedure; presence during active administration is characterized as participation in a medical procedure, not counseling. | Active administration must occur with a licensed physician physically present who assumes legal responsibility for the medical event. | Psychotherapy during active dosing without a physically present physician is treated as unauthorized practice of medicine; complaints are forwarded to the state medical board. |
| Louisiana | May practice clinical social work and psychotherapy within an agency under in-person or virtual LCSW supervision. | May independently practice clinical social work and psychotherapy but is expressly prohibited from prescribing, distributing, dispensing, or administering medications. | No explicit prescriber onsite requirement for psychotherapy sessions; medication administration must be performed by another licensed prescriber. | Social workers at all license levels may not prescribe, distribute, dispense, or administer medications; involvement is limited to psychotherapy and psychosocial services. |
| Oregon | From January 1, 2026, an LMSW who also holds a psilocybin facilitator license may conduct preparation and integration sessions under both licenses; the psilocybin service itself occurs under the facilitator license, not the social work license. | Clinical social workers may practice psychedelic-assisted therapy only under a separate psilocybin facilitator license; practicing as a coach or licensed psilocybin practitioner under the social work license alone is outside scope. | HB 2387 would let health care providers oversee psilocybin sessions after obtaining psilocybin licenses; no prescriber onsite requirement analogous to ketamine medical administration is specified. | Psychedelic administration and session facilitation occur under psilocybin facilitator rules, not the social work license; preparation and integration can use the social work license for dual-licensed facilitators. |
| Colorado | Social workers can practice psychedelic-assisted therapy within the scope of their license by obtaining a practitioner pathway in Colorado's framework, which allows licensed mental health providers to incorporate psychedelic-assisted services. | Licensed clinical social workers may obtain a clinical facilitator license and deliver therapy during psychedelic sessions after required training, supervised work, and consultation hours. | The framework does not specify an onsite medical prescriber requirement for psychedelic sessions; it focuses on facilitator training, mandatory initial consultation, and participant screening. | Facilitators must complete 150 hours of training, 40 hours of supervised participant work, and 40 hours of consultation; LCSWs as clinical facilitators can integrate psychedelic-assisted therapy into broader mental health care. |
| South Carolina | No specific social work guidance identified in the available advisory; social workers are not identified as authorized ketamine administrators. | No specific LCSW role identified in the ketamine advisory; role is implied to be limited to psychosocial care alongside medically supervised infusions. | Low-dose ketamine infusions are governed by physician and nursing board standards; ketamine administration is treated as a medical act requiring medical oversight. | Ketamine is treated as a drug requiring medical and nursing regulatory compliance; social workers are not identified as authorized administrators. |
| California | No LMSW-specific role permissions finalized; regulated psychedelic-assisted therapy facilitator tiers are under development by the Board of Behavioral Sciences. | LCSWs are contemplated as regulated mental health providers within the developing facilitator tiers with defined practicum, supervision, and qualification standards; detailed permissions pending. | Not finalized; the 2024 agenda discusses licensure, practicum, supervision, and participant safety protections for psychedelic-assisted therapy facilitators. | Psychedelic-assisted therapy facilitation is not yet fully implemented; until finalized, LCSWs remain bound by general psychotherapy scope and may not assume facilitator functions without the new regulated credential. |
| New York | No explicit LMSW-specific ketamine scope identified; training materials emphasize navigating scope rather than expanding it. | Licensed clinical social workers may receive approved continuing education on ketamine-assisted psychotherapy through providers recognized by the State Board for Social Work; must stay within existing psychotherapy scope. | No explicit prescriber onsite requirement identified for psychotherapy; medical providers handle ketamine administration. | Social workers must not extend into medication prescribing or administration; role is limited to psychotherapeutic and psychosocial services alongside legally authorized prescribers. |
| British Columbia (Canada) | Registrants may provide preparation and integration counseling within social work scope, provided services do not involve administration, handling, or facilitation of psychedelic substances. | Clinical registrants are prohibited from administering, dispensing, supervising ingestion, possessing, distributing, or facilitating access to controlled psychedelics; may not advertise psychedelic-assisted psychotherapy except within federally authorized trials or Special Access Program requests. | Psychotherapy during dosing is allowed only within a federally authorized clinical trial or Special Access Program request led by a prescriber legally authorized to obtain and administer the substance. | Psychotherapy alongside psychedelic administration outside existing legal pathways is outside scope for all registrant classes. |
Ethical Scenarios: Applying the NASW Code to Ketamine-Assisted Therapy
NASW has not issued a ketamine-specific code, so social workers must lean on the general Code of Ethics. The most direct obligations are competence, conflicts of interest, privacy and confidentiality, and informed consent. The closest published guidance is not binding: practice principles for psychedelic-assisted therapy align with NASW core values, but social workers still need to apply the Code standard by standard.
Competence and Informed Consent
A social worker with only general trauma training who begins offering ketamine-assisted therapy without study, supervision, or consultation is practicing outside the competence standard. The ethical response is to delay practice, get specific training or supervision, or refer the client elsewhere. Informed consent should follow state and federal requirements and spell out off-label use, non-ordinary states, and uncertainty about long-term outcomes.
Conflicts of Interest in Cash-Pay Clinics
Suppose a clinician owns a ketamine clinic and refers clients there while receiving a per-referral bonus. That is a real conflict of interest. The social worker must disclose ownership and any financial interest before the referral, remove the incentive from clinical judgment, and keep the client's interests primary. In cash-pay settings, commercialization pressure can blur boundaries, but disclosure and separation of financial interest are not optional.
Privacy During Integration
During integration, a client may reveal past substance use or suicidal thoughts. A family member who paid for treatment still has no automatic right to that information. Share only what the client authorized or what law requires, and document the basis. The confidentiality exception applies only for serious, foreseeable, and imminent harm.
Cash-pay ketamine clinics can blur boundaries when revenue pressure shapes treatment. Social workers must protect informed consent and dual-relationship risks, and remember that their duty is to the client, not the clinic's investors, even in fee-for-service settings where client welfare and autonomous decision-making should stay central.
Training and Certification Pathways for MSW-Level Clinicians
Ketamine-assisted psychotherapy training is a post-licensure add-on, not a replacement for the MSW vs LCSW sequence. Social workers first complete a CSWE-accredited MSW, accumulate state-required supervised clinical hours, and earn the LCSW. Only then does ketamine-specific training become relevant, because the work sits at the intersection of psychotherapy and medical oversight.
Post-Licensure KAP Training Varies Widely
No single national certification is required to practice ketamine-assisted psychotherapy. Programs such as PRATI, MAPS, Polaris Insight Center, and Integrative Psychiatry Institute (IPI) offer structured pathways, but prerequisites, cost, and CE approval differ. Fluence Training's ketamine-assisted psychotherapy course runs 18 weeks live online with 42 CE hours and a professional certificate. Polaris Insight lists 47 training hours and a $2,150 cohort fee, plus an optional $399 CE option.2 IPI's online program totals more than 140 hours with Level I certification.3 Alchemy Therapy offers a 32-hour online course over 7 weeks.4 Reported costs range from roughly $3,000 for online programs to $9,000 for in-person training, with hybrid cohorts often falling between $5,000 and $7,000, though not all programs carry social-work-specific CE approval.1 For ASWB ACE credit, the AEDP Institute offers a 17-hour seminar.5
Most MSW Programs Do Not Include KAP Coursework
Online MSW programs rarely integrate ketamine-assisted therapy into the degree. Brown School at Washington University offers 34 hours of professional development CE.6 The University of Vermont offers an online, non-credit training with 8 CEUs for licensed clinicians.7 These are post-degree options, so students should plan to add KAP training after licensure rather than during the MSW.
Supervised Practice and a Collaborating Prescriber
Training alone does not authorize prescribing. Ketamine remains a medical intervention, so social workers must work with a collaborating prescriber. Anne Bethune's practice required sending 75 to 90 letters to physicians before finding one willing to prescribe. Supervised practice hours vary by program and are not always published, so clinicians should confirm supervision requirements directly with the training provider.
Related Articles
From the Field: A Clinical Social Worker's Path Into Ketamine Therapy
Clinical social workers are already leading ketamine-assisted therapy, not simply assisting psychiatrists. Anne Bethune, an LCSW in Kansas City, opened Missouri's first ketamine-assisted therapy practice, KAP Kansas City, in 2019 and has now conducted more than 500 ketamine sessions.
A path built on existing clinical skills
Bethune was treating trauma clients, primarily rape victims, with traditional talk therapy when her agency asked her to earn an additional certification in EMDR in 2017. That training led her to study under Veronika Gold, a San Francisco-based therapist known for psychedelic-assisted therapy. The progression shows how relational and trauma-focused social work skills transfer directly into ketamine-assisted care.
The prescriber bottleneck
Because ketamine is a Schedule III controlled substance, social workers cannot prescribe it. Bethune sent 75 to 90 letters to doctors before finding one willing to prescribe, receiving few responses. The shortage of prescribing partners remains one of the most common obstacles cited by social workers pursuing ketamine-assisted therapy, and it points to the need for stronger interdisciplinary collaboration.
Leading policy, not just practice
Bethune has testified in multiple Missouri legislative sessions to expand access to psilocybin-assisted therapy. In spring 2026, lawmakers nearly passed legislation to study psilocybin for depression, substance use, and end-of-life care. Her path, as reported by the Missouri Independent (https://missouriindependent.com/2026/08/14/missouris-first-ketamine-therapy-practice-bets-on-what-comes-next/), shows that clinical social workers can lead emerging mental health treatments while advocating for the policies that shape them. For MSW students and early-career clinicians, Bethune's experience points toward the training and policy work required to move from talk therapy to ketamine-assisted practice.
Ketamine-assisted therapy is not just a medication session; it is a relational process, and clinical social workers are trained to hold that relationship with safety, intention, and ethical care.
Macro Practice, Access, and Policy: The Social Work Lens
In 2026, the Missouri House passed a psilocybin study bill 137-11, with the measure directing the Department of Mental Health to allocate $2 million in grants if funding is approved. The vote reflects a broader shift: Missouri lawmakers nearly passed legislation to study psilocybin for depression, substance use, and end-of-life care. Across states, the current pattern is study bills, research pathways, and regulated access proposals, not broad decriminalization.1
Health Equity Gaps Are Structural
Access is uneven. Ketamine and psychedelic-assisted therapy often require substantial out-of-pocket payment, insurance exclusions remain common, and clinics cluster in urban or higher-income areas. Rural social work clients, lower-income clients, and clients of color face longer waits, fewer trained providers, and weaker referral pathways. Those barriers are not accidental; they are built into how services are funded and where clinicians are recruited.
Policy Advocacy Is Clinical Work
Macro social work changes those conditions. Social workers can testify in legislative hearings, join coalitions supporting study bills and regulated access proposals, and push for language that funds culturally responsive training, rural telehealth, and supervision pipelines. Anne Bethune, a licensed clinical social worker in Kansas City, has testified in multiple legislative sessions to expand psilocybin-assisted therapy, showing the practitioner-to-policy path in action. These roles include challenging stigma, correcting myths, and treating psychedelic-assisted therapy as evidence-based where appropriate.2
Use the Research Base
With 93 completed psilocybin studies and over 160 in process nationwide, social workers have a concrete evidence platform for testimony and coalition work. The strongest contribution is not waiting for access to trickle down; it is using policy levers to make access deliberate, especially for marginalized communities that have been left out of early psychedelic care.
Billing, Documentation, and Risk: The Operational Side of Ketamine Practice
Payer and Coding Reality
Most off-label racemic ketamine for mental health is not covered by insurance, so patients typically pay out of pocket. The FDA-approved nasal spray esketamine (Spravato) is often reimbursable, but only under a REMS program that requires a two-hour observation after each dose. For Medicare in 2026, bundled codes G2082 (up to 56 mg) and G2083 (above 56 mg) include that observation time, with example rates around $906 and $1,290 locally. Commercial payers more often use J0013 per milligram with prior authorization. There is no unique CPT code for REMS observation, so practices use E/M and prolonged service codes when time thresholds are met. Check payer manuals because billing pathways for social workers vary by plan.
Who Bills What
Social workers bill the psychotherapy component using standard codes such as 90832, 90834, or 90837. The prescribing clinician bills the medical side: drug administration, medication management, and monitoring. When a social worker provides therapy before, during, or after the ketamine encounter, the payer must clearly see that psychotherapy is a separate, documented service, not folded into the prescriber's medical visit. For off-label ketamine, social workers may still bill for psychotherapy if it is medically necessary, even though the drug itself is often cash-pay.
Documentation and Risk
A strong chart includes a treatment plan, informed consent for off-label or REMS treatment, session notes that capture the altered-state work, clinical supervision or consultation notes, and a split-treatment agreement with the prescriber. Altered-state disclosures require a clear confidentiality plan: what gets documented, what remains privileged, and when duty to warn or report applies. Establish a crisis protocol for agitation, dissociation, or medical events, and confirm malpractice coverage includes ketamine-assisted psychotherapy or non-ordinary states of consciousness.
Social Work Salary Context: What Ketamine-Adjacent Roles Pay
The U.S. Bureau of Labor Statistics 2024 national estimates offer a broad reference for social work and related community service occupations. These figures are not ketamine clinic salaries. Actual pay varies by state, employer, and clinical responsibilities.
| Occupation | Median Annual Wage | 25th Percentile | 75th Percentile |
|---|---|---|---|
| Social Workers, All Other | $69,480 | $52,010 | $95,390 |
| Healthcare Social Workers | $68,090 | $55,360 | $83,410 |
| Counselors, Social Workers, and Other Community and Social Service Specialists | $57,480 | $45,750 | $75,090 |
Career Settings and Job Roles for Social Workers in Ketamine Clinics
Job postings from 2024 through 2026 show social workers entering ketamine clinics in direct clinical, telehealth, and leadership roles. Settings range from outpatient ketamine clinics and group practices to hospital-affiliated treatment programs. The most common team structure pairs an LCSW or master's-level therapist with a prescriber and registered nursing staff.
| Setting | Social Work Role | Typical Team | Salary Signals |
|---|---|---|---|
| Ketamine-focused outpatient practice | Licensed Clinical Social Worker (LCSW) providing ketamine-assisted psychotherapy and related mental health services | Multidisciplinary team often includes a psychiatrist (MD/DO) or psychiatric nurse practitioner (NP), registered nurses, and therapists providing preparation and integration psychotherapy | Hourly rates from $32 to $60; full-time salary ranges of $65,000 to $82,000 per year |
| Telehealth ketamine-assisted psychotherapy practice | Master's-level mental health professional (often LCSW) serving as KAP therapist, providing preparation, dosing-session support, and integration therapy via telehealth | Collaborates with a prescriber (psychiatrist or psychiatric NP/APRN) who manages ketamine dosing in an outpatient or virtual clinic structure | 2024 posting lists $70.00 per hour for very part-time work (about 2 hours per week, 2 weeks per month) |
| Outpatient ketamine-assisted therapy clinic (BrainStim Health, Vancouver) | Clinical counsellor or psychotherapist role suitable for master's-level clinicians, including social workers, providing ketamine-assisted therapy | Works alongside medical staff who administer ketamine (prescriber and nursing staff) and other therapists providing integration and ongoing psychotherapy | 2026 posting lists $50.00 to $60.00 per hour; full-time and part-time roles available |
| Specialized ketamine clinic (Ember Health, New York) | Clinic Director role that may be held by a licensed mental health clinician, including experienced LCSWs, overseeing clinic operations and clinical quality | Leads a team including psychiatrists or prescribing clinicians, registered nurses managing infusions, and therapists or social workers providing ketamine-related psychotherapy | Total compensation of $300,245 to $311,905 per year with comprehensive benefits |
| Treatment center with ketamine or psychedelic-adjacent services | Clinical Director position explicitly open to LCSW candidates, aligning with leadership roles in ketamine or psychedelic-adjacent programs | Directs an interdisciplinary treatment team that may include prescribers, nursing staff, and therapists providing specialized behavioral health services | 2025 posting lists $110,000 to $125,000 per year |
| Hospital- or clinic-affiliated outpatient addiction treatment program | LCSW Clinical Director overseeing an outpatient addiction treatment program that may include ketamine or other adjunctive treatments | Oversees outpatient interdisciplinary team commonly including prescribing clinicians, nursing staff, and therapists or social workers delivering behavioral health services | Advertised at $125,000 to $150,000 per year plus benefits |
| Group counseling practice (Salem Counseling and Consulting PLLC) | Therapist role seeking experience or interest in trauma-informed, evidence-based care and ketamine-assisted psychotherapy; suitable for licensed social workers as integration or KAP therapists | Part of a group practice where therapists collaborate with external or internal prescribers who provide ketamine, focusing on psychotherapy and integration services | Starts as a 1099 contract with competitive per-session or per-service compensation; rates discussed during interview |
